London calling logo

London Calling 2024 - Speakers

Speakers

Subscribe

Check out the line up of speaking at London Calling 2024.

Oxford Nanopore Technologies

Dr. Clemens Jakobi

Clemens Jakobi
Job title
Institution
Lonza, Switzerland
Biography

Dr. Clemens Jakobi is Senior Director Commercial Development in the mRNA Business Unit of Lonza. In his current role, Clemens is driving forward growth projects in the area of the mRNA modality. Together with a team of experts in Lonza, he is developing an mRNA manufacturing platform to enable an agile response to unmet medical needs.

Clemens completed the pharmacy degree program at the University of Heidelberg in Germany and is a licensed pharmacist in Switzerland. He holds a PhD in Microbiology from the University of Freiburg and an MBA degree from The State University of New York. Clemens thrives on making innovative projects real and leading diverse, cross-functional teams. During his tenure at Novartis (2005–2018), he launched an eyesight-saving treatment in Europe. Since joining Lonza in 2018, he has championed major expansion projects. In his free time, he plays saxophone and clarinet and has contributed to several recordings of traditional and recent Swiss children’s songs.

Recent publications

Lonza. Current and emerging technologies to optimize mRNA manufacturing. https://www.lonza.com/knowledge-center/biologics/post/mrna-optimize-manufacturing (2023) [Accessed: 18 April 2024]

Talks at this conference

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag